Avery W. Catlin
2014
In 2014, Avery W. Catlin earned a total compensation of $1.2M as Senior Vice President and Chief Financial Officer at Celldex Therapeutics, a 12% decrease compared to previous year.
Compensation breakdown
| Bonus | $102,097 |
|---|---|
| Option Awards | $799,038 |
| Salary | $317,017 |
| Other | $5,717 |
| Total | $1,223,869 |
Catlin received $799K in option awards, accounting for 65% of the total pay in 2014.
Catlin also received $102.1K in bonus, $317K in salary and $5.7K in other compensation.
Rankings
In 2014, Avery W. Catlin's compensation ranked 6,680th out of 13,032 executives tracked by ExecPay. In other words, Catlin earned more than 48.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,680 out of 13,032 | 49th |
Division Manufacturing | 2,448 out of 4,966 | 51st |
Major group Chemicals And Allied Products | 825 out of 1,686 | 51st |
Industry group Drugs | 648 out of 1,365 | 53rd |
Industry In Vitro and In Vivo Diagnostic Substances | 29 out of 72 | 60th |
Source: SEC filing on April 28, 2017.
Catlin's colleagues
We found four more compensation records of executives who worked with Avery W. Catlin at Celldex Therapeutics in 2014.